579 related articles for article (PubMed ID: 18772849)
1. [The role of matrix metalloproteinases in the pathogenesis of diabetes mellitus and progression of diabetes retinopathy].
Naduk-Kik J; Hrabec E
Postepy Hig Med Dosw (Online); 2008 Sep; 62():442-50. PubMed ID: 18772849
[TBL] [Abstract][Full Text] [Related]
2. [Type IV collagenases (MMP-2 and MMP-9) and their substrates--intracellular proteins, hormones, cytokines, chemokines and their receptors].
Hrabec E; Naduk J; Strek M; Hrabec Z
Postepy Biochem; 2007; 53(1):37-45. PubMed ID: 17718386
[TBL] [Abstract][Full Text] [Related]
3. The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases.
Cabral-Pacheco GA; Garza-Veloz I; Castruita-De la Rosa C; Ramirez-Acuña JM; Perez-Romero BA; Guerrero-Rodriguez JF; Martinez-Avila N; Martinez-Fierro ML
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33419373
[TBL] [Abstract][Full Text] [Related]
4. [The role of metalloproteinases in modification of extracellular matrix in invasive tumor growth, metastasis and angiogenesis].
Fink K; Boratyński J
Postepy Hig Med Dosw (Online); 2012 Sep; 66():609-28. PubMed ID: 23001203
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinases 2 and 9, and extracellular matrix in Kaposi's sarcoma.
Bongiorno MR; Doukaki S; Ferro G; Aricò M
Dermatol Ther; 2010; 23 Suppl 2():S33-6. PubMed ID: 20482566
[TBL] [Abstract][Full Text] [Related]
6. Physiological Properties, Functions, and Trends in the Matrix Metalloproteinase Inhibitors in Inflammation-Mediated Human Diseases.
Kim IS; Yang WS; Kim CH
Curr Med Chem; 2023; 30(18):2075-2112. PubMed ID: 36017851
[TBL] [Abstract][Full Text] [Related]
7. Biochemical and Biological Attributes of Matrix Metalloproteinases.
Cui N; Hu M; Khalil RA
Prog Mol Biol Transl Sci; 2017; 147():1-73. PubMed ID: 28413025
[TBL] [Abstract][Full Text] [Related]
8. Regulation of Matrix Metalloproteinase in the Pathogenesis of Diabetic Retinopathy.
Kowluru RA; Mishra M
Prog Mol Biol Transl Sci; 2017; 148():67-85. PubMed ID: 28662829
[TBL] [Abstract][Full Text] [Related]
9. Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.
Wang X; Khalil RA
Adv Pharmacol; 2018; 81():241-330. PubMed ID: 29310800
[TBL] [Abstract][Full Text] [Related]
10. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats.
Zhang X; Sakamoto T; Hata Y; Kubota T; Hisatomi T; Murata T; Ishibashi T; Inomata H
Exp Eye Res; 2002 May; 74(5):577-84. PubMed ID: 12076079
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase-2 expression and apoptogenic activity in retinal pericytes: implications in diabetic retinopathy.
Yang R; Liu H; Williams I; Chaqour B
Ann N Y Acad Sci; 2007 Apr; 1103():196-201. PubMed ID: 17332085
[TBL] [Abstract][Full Text] [Related]
12. Expression and activation of MMP -2, -3, -9, -14 are induced in rat colon after abdominal X-irradiation.
Strup-Perrot C; Vozenin-Brotons MC; Vandamme M; Benderitter M; Mathe D
Scand J Gastroenterol; 2006 Jan; 41(1):60-70. PubMed ID: 16373278
[TBL] [Abstract][Full Text] [Related]
13. Matrix Gelatinases in Atherosclerosis and Diabetic Nephropathy: Progress and Challenges.
Dimas GG; Didangelos TP; Grekas DM
Curr Vasc Pharmacol; 2017; 15(6):557-565. PubMed ID: 28155628
[TBL] [Abstract][Full Text] [Related]
14. Distinct modes of collagen type I proteolysis by matrix metalloproteinase (MMP) 2 and membrane type I MMP during the migration of a tip endothelial cell: insights from a computational model.
Karagiannis ED; Popel AS
J Theor Biol; 2006 Jan; 238(1):124-45. PubMed ID: 16005020
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinases in diabetic retinopathy: potential role of MMP-9.
Kowluru RA; Zhong Q; Santos JM
Expert Opin Investig Drugs; 2012 Jun; 21(6):797-805. PubMed ID: 22519597
[TBL] [Abstract][Full Text] [Related]
16. Microvascular basement membranes in diabetes mellitus.
Tsilibary EC
J Pathol; 2003 Jul; 200(4):537-46. PubMed ID: 12845621
[TBL] [Abstract][Full Text] [Related]
17. Importance of balance between extracellular matrix synthesis and degradation in basement membrane formation.
Amano S; Akutsu N; Matsunaga Y; Nishiyama T; Champliaud MF; Burgeson RE; Adachi E
Exp Cell Res; 2001 Dec; 271(2):249-62. PubMed ID: 11716537
[TBL] [Abstract][Full Text] [Related]
18. Role of metalloproteinases MMP-9 and MT1-MMP in CXCL12-promoted myeloma cell invasion across basement membranes.
Parmo-Cabañas M; Molina-Ortiz I; Matías-Román S; García-Bernal D; Carvajal-Vergara X; Valle I; Pandiella A; Arroyo AG; Teixidó J
J Pathol; 2006 Jan; 208(1):108-18. PubMed ID: 16278822
[TBL] [Abstract][Full Text] [Related]
19. Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients.
Lobmann R; Ambrosch A; Schultz G; Waldmann K; Schiweck S; Lehnert H
Diabetologia; 2002 Jul; 45(7):1011-6. PubMed ID: 12136400
[TBL] [Abstract][Full Text] [Related]
20. [Implication of extracellular matrix metalloproteinases in the course of chronic inflammatory airway diseases].
Lechapt-Zalcman E; Escudier E
Morphologie; 2000 Jun; 84(265):45-9. PubMed ID: 11048298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]